Better Therapeutics Inc. (BTTX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Better Therapeutics Inc. (BTTX:NASDAQ), powered by AI.

Current Price
$0.00
P/E Ratio
-0.0
Market Cap
2,356
Sector
Healthcare
What is the Better Therapeutics Inc. stock price forecast?

Better Therapeutics Inc. is currently trading at $0.00. View real-time AI analysis on Alpha Lenz.

What is Better Therapeutics Inc. insider trading activity?

View the latest insider trading data for Better Therapeutics Inc. on Alpha Lenz.

What is Better Therapeutics Inc.'s P/E ratio?

Better Therapeutics Inc.'s P/E ratio is -0.0.

Better Therapeutics Inc.

NASDAQ · BTTX
$0.00+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Better Therapeutics Inc.'s future dividend policy...
Alpha Chat Insight

Better Therapeutics Inc. trades at a P/E of -0.0 (undervalued) with modest ROE of -222.0%.

Ask for details

Company Overview

Better Therapeutics Inc. is a digital therapeutics company focused on developing prescription digital therapies to treat cardiometabolic diseases. The company integrates cognitive behavioral therapy (CBT) with digital platforms, aiming to provide healthcare solutions that can be prescribed by physicians. A key aspect of its offerings is the utilization of software-based treatment methodologies that are designed to modify behavior and assist in managing conditions such as diabetes, hypertension, and chronic kidney disease. Better Therapeutics operates at the intersection of technology and healthcare, contributing to the growing field of digital health solutions that offer personalized treatment plans without the need for traditional pharmaceuticals. Founded in 2015 and headquartered in San Francisco, California, Better Therapeutics plays a significant role in advancing healthcare innovation by addressing unmet medical needs through digital intervention. Its efforts reflect a shift towards preventive care and the application of behavioral sciences in clinical practice, demonstrating the increasing importance of technology in managing chronic health conditions.

CEOMr. Frank L. Karbe
SectorHealthcare
IndustryBiotechnology
Employees54

Company Statistics

FY 2022

Profile

$2.36KMarket Cap
$0.00Revenue
0.00Shares Out
54Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

-0.00P/E
-0.00P/B
N/AEV/Sales
0.02EV/EBITDA
-0.00P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-107.60%ROA
-221.99%ROE
-103.55%ROIC

Financial Health

$15.74MCash & Cash Equivalents
$8.10MNet Debt
-2652.06%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Better Therapeutics Inc. (ticker: BTTX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 54 employees. Market cap is $2,356.

The current price is $0 with a P/E ratio of -0x and P/B of -0x.

ROE is -221.99%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Better Therapeutics Inc. (BTTX) Stock Forecast 2026 $0.00 — Price, Financials & Analyst Targets | Alpha Lenz